Sarcopenia and MASLD/associated fibrosis share common pathogenic mechanisms, including systemic low-grade chronic inflammation, insulin resistance, oxidative stress, hyperammonemia, abnormal myokine secretion, and other pathway disturbances (42). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.